Literature DB >> 27033522

Phosphatidylethanolamine binding protein 4 (PEBP4) is a secreted protein and has multiple functions.

Huan He1, Dan Liu2, Hui Lin1, Shanshan Jiang3, Ying Ying4, Shao Chun5, Haiteng Deng6, Joseph Zaia5, Rong Wen7, Zhijun Luo8.   

Abstract

Phosphatidylethanolamine binding proteins (PEBP) represent a superfamily of proteins that are conserved from bacteria to humans. In mammals, four members have been identified, PEBP1-4. To determine the functional differences among PEBP1-4 and the underlying mechanism for their actions, we performed a sequence alignment and found that PEBP4 contains a signal peptide and potential glycosylation sites, whereas PEBP1-3 are intracellular proteins. To test if PEBP4 is secreted, we made constructs with Myc epitope at the amino (N) terminus or carboxyl (C) terminus to mask the signal sequence or keep it free, respectively. Our data revealed that both mouse and human PEBP4 were secreted when the epitope was tagged at their C-terminus. To our surprise, secretion was dependent upon the C-terminal conserved domain in addition to the N-terminal signal sequence. When the epitope was placed to the N-terminus, the recombinant protein failed to secrete and instead, was retained in the cytoplasm. Mass spectrometry detected asparagine (N)-glycosylation on the secreted PEBP4. Although overexpression of N-terminal tagged PEBP4 resulted in an inhibition of ERK activation by EGF, that with a C-terminal epitope tag did not have such an effect. Likewise, transfection of PEBP4 shRNA did not appear to affect ERK activation, suggesting that PEBP4 does not participate in the regulation of this pathway. In contrast, PEBP4 siRNA suppressed phosphorylation of Act at S473. Therefore, our results suggest that PEBP4 is a multifunctional protein and can be secreted. It will be important to investigate the mechanism by which PEBP4 is secreted and regulates cellular events.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Act; ERK; Glycosylation; PEBP4; Secretion; Signal peptide

Mesh:

Substances:

Year:  2016        PMID: 27033522      PMCID: PMC5336313          DOI: 10.1016/j.bbamcr.2016.03.022

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  38 in total

1.  Optimized signal peptides for the development of high expressing CHO cell lines.

Authors:  Lars Kober; Christoph Zehe; Juergen Bode
Journal:  Biotechnol Bioeng       Date:  2013-01-17       Impact factor: 4.530

2.  hPEBP4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapy.

Authors:  Jianming Qiu; Guangen Yang; Zhong Shen; Ya Xie; Lewei Wang
Journal:  Int J Colorectal Dis       Date:  2012-07-17       Impact factor: 2.571

3.  Expression of PEBP4 protein correlates with the invasion and metastasis of colorectal cancer.

Authors:  Hongyi Liu; Qingling Kong; Bing Li; Yuanxiang He; Peng Li; Baoqing Jia
Journal:  Tumour Biol       Date:  2011-11-29

4.  Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest.

Authors:  Xiaojian Wang; Nan Li; Hongzhe Li; Bin Liu; Jianming Qiu; Taoyong Chen; Xuetao Cao
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

5.  Purification and structural analysis of hippocampal cholinergic neurostimulating peptide.

Authors:  K Ojika; S Kojima; Y Ueki; N Fukushima; K Hayashi; M Yamamoto
Journal:  Brain Res       Date:  1992-02-14       Impact factor: 3.252

6.  Distribution of hippocampal cholinergic neurostimulating peptide (HCNP)-like immunoreactivity in organs and tissues of young Wistar rats.

Authors:  E Katada; S Mitake; N Matsukawa; Y Otsuka; Y Tsugu; O Fujimori; K Ojika
Journal:  Histochem Cell Biol       Date:  1996-01       Impact factor: 4.304

7.  A chip-based amide-HILIC LC/MS platform for glycosaminoglycan glycomics profiling.

Authors:  Gregory O Staples; Michael J Bowman; Catherine E Costello; Alicia M Hitchcock; James M Lau; Nancy Leymarie; Christine Miller; Hicham Naimy; Xiaofeng Shi; Joseph Zaia
Journal:  Proteomics       Date:  2009-02       Impact factor: 3.984

8.  Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.

Authors:  H Li; F Huang; L Fan; Y Jiang; X Wang; J Li; Q Wang; H Pan; J Sun; X Cao; X Wang
Journal:  Oncogene       Date:  2013-11-25       Impact factor: 9.867

9.  Regulation of human myoblast differentiation by PEBP4.

Authors:  Reynaldo Garcia; Joan Grindlay; Oliver Rath; Frances Fee; Walter Kolch
Journal:  EMBO Rep       Date:  2009-02-06       Impact factor: 8.807

10.  Silencing of human phosphatidylethanolamine-binding protein 4 enhances rituximab-induced death and chemosensitization in B-cell lymphoma.

Authors:  Kai Wang; Yu Jiang; Weiyan Zheng; Zhiyong Liu; Hui Li; Jianzhou Lou; Meidi Gu; Xiaojian Wang
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more
  10 in total

1.  Phosphorylation at S153 as a Functional Switch of Phosphatidylethanolamine Binding Protein 1 in Cerebral Ischemia-Reperfusion Injury in Rats.

Authors:  Zhong Wang; Jiyuan Bu; Xiyang Yao; Chenglin Liu; Haitao Shen; Xiang Li; Haiying Li; Gang Chen
Journal:  Front Mol Neurosci       Date:  2017-10-31       Impact factor: 5.639

2.  Expression of uncharacterized male germ cell-specific genes and discovery of novel sperm-tail proteins in mice.

Authors:  Jun Tae Kwon; Sera Ham; Suyeon Jeon; Youil Kim; Seungmin Oh; Chunghee Cho
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

3.  The Roles And Signaling Pathways Of Phosphatidylethanolamine-Binding Protein 4 In Tumors.

Authors:  Zi-Kang Luo; Qiong-Feng Chen; Xiaoqin Qu; Xiao-Yan Zhou
Journal:  Onco Targets Ther       Date:  2019-09-18       Impact factor: 4.147

4.  Diagnostic value of phosphatidylethanolamine binding protein 4 levels in patients receiving nursing interventions for advanced chronic kidney disease.

Authors:  Peipei He; Congli Zhou; Huajuan Shen
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

Review 5.  Florigen and its homologs of FT/CETS/PEBP/RKIP/YbhB family may be the enzymes of small molecule metabolism: review of the evidence.

Authors:  Olga Tsoy; Arcady Mushegian
Journal:  BMC Plant Biol       Date:  2022-01-27       Impact factor: 4.215

6.  The tobacco phosphatidylethanolamine-binding protein NtFT4 increases the lifespan of Drosophila melanogaster by interacting with the proteostasis network.

Authors:  Philip Känel; Gundula A Noll; Katrin Schroedter; Elke Naffin; Julia Kronenberg; Franziska Busswinkel; Richard M Twyman; Christian Klämbt; Dirk Prüfer
Journal:  Aging (Albany NY)       Date:  2022-04-08       Impact factor: 5.682

7.  PEBP4 Directs the Malignant Behavior of Hepatocellular Carcinoma Cells via Regulating mTORC1 and mTORC2.

Authors:  Qiongfeng Chen; Jingguang Jin; Wenhui Guo; Zhimin Tang; Yunfei Luo; Ying Ying; Hui Lin; Zhijun Luo
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

8.  Hepatocyte-Conditional Knockout of Phosphatidylethanolamine Binding Protein 4 Aggravated LPS/D-GalN-Induced Acute Liver Injury via the TLR4/NF-κB Pathway.

Authors:  Xiao-Qin Qu; Qiong-Feng Chen; Qiao-Qing Shi; Qian-Qian Luo; Shuang-Yan Zheng; Yan-Hong Li; Liang-Yu Bai; Shuai Gan; Xiao-Yan Zhou
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

9.  Phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the NF-κB signaling pathway.

Authors:  Qianqian Luo; Yuanyi Ling; Yufei Li; Xiaoqin Qu; Qiaoqing Shi; Shuangyan Zheng; Yanhong Li; Yonghong Huang; Xiaoyan Zhou
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

10.  Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder.

Authors:  Mireia Pagerols; Vanesa Richarte; Cristina Sánchez-Mora; Paula Rovira; María Soler Artigas; Iris Garcia-Martínez; Eva Calvo-Sánchez; Montse Corrales; Bruna Santos da Silva; Nina Roth Mota; Marcelo Moraes Victor; Luis Augusto Rohde; Eugenio Horacio Grevet; Claiton Henrique Dotto Bau; Bru Cormand; Miguel Casas; Josep Antoni Ramos-Quiroga; Marta Ribasés
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.